- The report contains detailed information about Iris Biotechnologies Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
- Another part of the report is a SWOT-analysis carried out for Iris Biotechnologies Inc.. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
- The Iris Biotechnologies Inc. financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
- In the part that describes Iris Biotechnologies Inc. competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
- Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Iris Biotechnologies Inc. business.
About Iris Biotechnologies Inc.
Iris BioTechnologies Inc., a development stage life science company, focuses on developing solutions for the detection and monitoring of monogenic and complex genomic diseases.
The company is developing a nano-biochip technology platform using a convergence of scientific disciplines in nanotechnology, semiconductor manufacturing, microfluidics, chemistry, molecular biology, genetics, genomics, and information technology. It intends to diagnosis and treat patients with breast cancer, neurological disorders, heart disease, diabetes, and other gene-related metabolic problems.
The companys technology platform includes: Oligonucleotide and peptide nucleic acid (PNA) probes with binding affinity and specificity that are the ideal length and purified; a proprietary binding system to secure probes to a soft metal chip surface; controlled probe spacing and chip surface design to enhance sensitivity; microfluidics and the use of paramagnetic labels with a magnetic field for hybridization; a chip design and manufacturing process; use of robotics for precise automated chip manufacturing; and an information technology system based on proprietary algorithms for analysis, correlation, and classification of test results.
The company launched Health Passport in its BioWindows 2.0 Informatics System for personalized and targeted medicine. BioWindows is an artificial intelligent system, which includes a database with molecular signatures, in-depth patient demographics and lifestyle information, family medical histories and treatment-response profiles for various diseases.
The Iris BioWindows database consists of data fields for patient demographic information, personal medical history, family medical history, and gene expression information is in use for storing actual patient information. Physicians, with the patients consent, can view information by choosing any medical record from their personal list of patients.
The company is working on gene markers for a CancerChip and specific markers associated with prostrate, lung, liver, kidney and ovarian cancers. It is working on the selection of discovered genes to be included in other products, such as the NeuroChip and CardioChip.
The companys customers include Stanford, UCSF, M.D. Anderson Cancer Center, the National Cancer Institute (NIH), Quest Diagnostics, Laboratory Corporation, Sutter Medical, and Kaiser Permanente.
The company competes with Genomic Health Inc.
Iris BioTechnologies Inc. was founded in 1999.
The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.
1. IRIS BIOTECHNOLOGIES INC. COMPANY PROFILE
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History
2. IRIS BIOTECHNOLOGIES INC. BUSINESS OVERVIEW
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units
3. IRIS BIOTECHNOLOGIES INC. SWOT ANALYSIS
4. IRIS BIOTECHNOLOGIES INC. FINANCIAL ANALYSIS
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot
5. IRIS BIOTECHNOLOGIES INC. COMPETITORS AND INDUSTRY ANALYSIS
5.1. Iris Biotechnologies Inc. Direct Competitors
5.2. Comparison of Iris Biotechnologies Inc. and Direct Competitors Financial Ratios
5.3. Comparison of Iris Biotechnologies Inc. and Direct Competitors Stock Charts
5.4. Iris Biotechnologies Inc. Industry Analysis
5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
5.4.2. Iris Biotechnologies Inc. Industry Position Analysis
6. IRIS BIOTECHNOLOGIES INC. NEWS & EVENTS
6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events
7. IRIS BIOTECHNOLOGIES INC. EXPERTS REVIEW1
7.1. Experts Opinion
7.2. Experts Estimates
8. IRIS BIOTECHNOLOGIES INC. ENHANCED SWOT ANALYSIS2
9. UNITED STATES PESTEL ANALYSIS2
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors
10. IRIS BIOTECHNOLOGIES INC. IFE, EFE, IE MATRICES2
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix
11. IRIS BIOTECHNOLOGIES INC. PORTER FIVE FORCES ANALYSIS2
12. IRIS BIOTECHNOLOGIES INC. VRIO ANALYSIS2
APPENDIX: RATIO DEFINITIONS
LIST OF TABLES
Iris Biotechnologies Inc. Key Facts
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Iris Biotechnologies Inc. Key Executives
Key Executives Biographies1
Key Executives Compensations1
Iris Biotechnologies Inc. Major Shareholders
Iris Biotechnologies Inc. History
Iris Biotechnologies Inc. Products
Revenues by Segment
Revenues by Region
Iris Biotechnologies Inc. Offices and Representations
Iris Biotechnologies Inc. SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Iris Biotechnologies Inc. Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Iris Biotechnologies Inc. Capital Market Snapshot
Iris Biotechnologies Inc. Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Pharmaceuticals and Biotechnology Industry Statistics
Iris Biotechnologies Inc. Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Iris Biotechnologies Inc. Consensus Recommendations1
Analyst Recommendation Summary1
Price Target Summary1
Experts Recommendation Trends1
Revenue Estimates Analysis1
Earnings Estimates Analysis1
Revenue Estimates Trend1
Earnings Estimates Trend1
LIST OF FIGURES
Iris Biotechnologies Inc. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Iris Biotechnologies Inc. 1-year Stock Charts
Iris Biotechnologies Inc. 5-year Stock Charts
Iris Biotechnologies Inc. vs. Main Indexes 1-year Stock Chart
Iris Biotechnologies Inc. vs. Direct Competitors 1-year Stock Charts
Iris Biotechnologies Inc. Article Density Chart
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.
Enhanced SWOT Analysis
- How to use the strengths to take advantage of the opportunities?
- How to use the strengths to reduce likelihood and impact of the threats?
- How to overcome the weaknesses that obstruct taking advantage of the opportunities?
- How to overcome the weaknesses that can make the threats a reality?
Key Factors Examined by PESTEL Analysis:
- Legal – What laws and legislation will exert influence on the style the business is carried out?
IFE, EFE, IE Matrices
Porter Five Forces Analysis
- What composes a threat of substitute products and services?
- Is there a threat of new competitors entering the market?
- What is the intensity of competitive rivalry?
- How big is the bargaining power of buyers?
- How significant is the bargaining power of suppliers?
- Tangible resources
- Intangible resources
- Innovation and Creativity
- Organizational capabilities
- Costly to imitate?
- Organized properly?